Listed by the USPTO as SCHLIENTZ, NATHAN W
Tech Center 1600 • Art Units: 1616
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19539311 | COMPOSITIONS AND METHODS FOR DIFFERENTIAL RELEASE OF 1-METHYLCYCLOPROPENE | Non-Final OA | Verdant Technologies, LLC |
| 17232710 | COMPOSITIONS AND METHODS FOR DIFFERENTIAL RELEASE OF 1-METHYLCYCLOPROPENE | Non-Final OA | Verdant Technologies, LLC |
| 18598213 | PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN | Final Rejection | The Procter & Gamble Company |
| 18719751 | NEW COATING SYSTEM (I) | Non-Final OA | DSM IP Assets B.V. |
| 18717319 | NON-STICKY SMOOTH STABLE COMPOSITION | Final Rejection | L'OREAL |
| 18651001 | WATER-IN-OIL EMULSION COMPOSITION | Final Rejection | L'OREAL |
| 17792607 | HERBICIDE COMPOSITIONS COMPRISING DICAMBA MONOETHANOLAMINE SALT AND A PPO-INHIBITOR | Final Rejection | MONSANTO TECHNOLOGY LLC |
| 18249111 | SOLID PHASE MATRIX FOR CROP PROTECTION | Non-Final OA | North Carolina State University |
| 19113566 | OLEOSOME COMPOSITION | Non-Final OA | CARGILL, INCORPORATED |
| 18622705 | MNO NANOMATERIAL BASED INHIBITORS OF INFLAMMATION AND CANCER METASTASIS | Non-Final OA | NewSouth Innovations Pty Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy41.3% of resolved applications examined by Nathan W Schlientz were allowed (814 resolved cases), compared with 24.5% across Art Unit 1616 over the last five years.
This examiner's interview lift is -18.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Nathan W Schlientz took 1,328 days on average from filing to allowance.
Nathan W Schlientz examines applications in Art Unit 1616 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
